|
|||||||||||||||
|
|||||||||||
|
|||||||||||
CRES Programs has partnered with a non-admitted carrier to address the insurance needs of Biotech companies by providing a solution that combines many coverage features on one form. This comprehensive insurance package includes Property, GL, Products, E&O and Clinical Trials. Territory scope is worldwide.
Target Market includes:
Drug discovery/development companies
MedTech/Device Companies
CRO’s
CMO’s
Contract research service providers
Others involved in the drug development supply chain
Limits are available up to $10M. Competitive premiums and 24-48 hour quote turn around is provided.
Product summary available here.
